Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | BTAIQBioXcel Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $642.00K |
| Revenue, yoy | −71.7% |
| Net income | $69.90M |
| Net income, yoy | −17.3% |
| Net margin | -10,887.4% |
| Free cash flow | $57.62M |
| FCF margin | -8,974.3% |
| EPS, diluted | $5.73 |
Add another company.